跳至主要内容
临床试验/CTRI/2021/08/035350
CTRI/2021/08/035350已完成未知

Comparison of clinical efficacy and safety of oral and intralesional tranexamic acid in treatment of melasma - OITAM

Department of Dermatology0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with clinical diagnosis of melasma.
  • 2. Patients above the age of 18 years and below the age of 50 years.

排除标准

  • 1. Patients with a history of bleeding disorders
  • 2. Patient taking oral anticoagulants, hormonal drugs like estrogen, progesterone, oral contraceptive pills and other female hormonal analogues.
  • 3. Patients with past history of thrombotic disease like DVT.
  • 4. Patients with family history of thrombotic disease.
  • 5. Patients with known allergy to tranexamic acid.
  • 6. Pregnant and lactation mothers.
  • 7. Patients using photosensitizing drugs such as nonsteroidal anti-inflammatory drugs, tetracycline, spironolactone, phenytoin, carbamazepine, use of other depigmenting oral or topical agents.
  • 8. Patients with any other facial dermatoses.
  • 9. Patients with a history of any treatment for melasma in the past 6 months.
  • 10. Patients with significant systemic illness.

研究者

相似试验

Effectiveness and safety of oral and intralesional... | 临床试验